Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Muzaffar H Qazilbash

Showing results (51-60 of 188) with videos related to

Pageof 19
Sort By:
Hematological Oncology|November 11, 2021
Post-relapse survival in Waldenstrom macroglobulinemia patients experiencing therapy failure following autologous transplantationSairah Ahmed, Qiuhong Zhao, Walter Hanel, et al.
British Journal of Haematology|May 10, 2017
A randomized phase II study of standard-dose versus high-dose rituximab with BEAM in autologous stem cell transplantation for relapsed aggressive B-cell non-hodgkin lymphomas: long term resultsSamer A Srour, Shaoying Li, Uday R Popat, et al.
Advances in Hematology|November 24, 2011
Steroid-Refractory Acute GVHD: Predictors and OutcomesJason R Westin, Rima M Saliba, Marcos De Lima, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 20, 2013
High-dose chemotherapy and autologous stem cell transplantation for nodular lymphocyte-predominant Hodgkin lymphomaMeghan Karuturi, Chitra Hosing, Michelle Fanale, et al.
Cytotherapy|August 26, 2010
Adoptive transfer of PR1 cytotoxic T lymphocytes associated with reduced leukemia burden in a mouse acute myeloid leukemia xenograft modelQing Ma, Changqing Wang, Dan Jones, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 7, 2022
Safety and Efficacy of Combination Maintenance Therapy with Ixazomib and Lenalidomide in Patients with Posttransplant MyelomaKrina K Patel, Jatin J Shah, Lei Feng, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 15, 2019
Comparison of Outcomes of Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma Using Three Different Conditioning RegimensHossein Maymani, Paul Lin, Rima M Saliba, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 18, 2012
Significance of persistent cytogenetic abnormalities on myeloablative allogeneic stem cell transplantation in first complete remissionBetul Oran, Uday Popat, Gabriella Rondon, et al.
American Journal of Hematology|December 11, 2022
Prognostic significance of measurable residual disease in patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation in second or later complete remissionOren Pasvolsky, Rima M Saliba, Celina Ledesma, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 15, 2009
Outcome of allogeneic hematopoietic stem cell transplantation in patients with low left ventricular ejection fractionMuzaffar H Qazilbash, Ali Imran Amjad, Suhail Qureshi, et al.
Pageof 19

Showing results (51-60 of 188) with videos related to

Sort By:
Pageof 19
Hematological Oncology|November 11, 2021
Post-relapse survival in Waldenstrom macroglobulinemia patients experiencing therapy failure following autologous transplantationSairah Ahmed, Qiuhong Zhao, Walter Hanel, et al.
British Journal of Haematology|May 10, 2017
A randomized phase II study of standard-dose versus high-dose rituximab with BEAM in autologous stem cell transplantation for relapsed aggressive B-cell non-hodgkin lymphomas: long term resultsSamer A Srour, Shaoying Li, Uday R Popat, et al.
Advances in Hematology|November 24, 2011
Steroid-Refractory Acute GVHD: Predictors and OutcomesJason R Westin, Rima M Saliba, Marcos De Lima, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 20, 2013
High-dose chemotherapy and autologous stem cell transplantation for nodular lymphocyte-predominant Hodgkin lymphomaMeghan Karuturi, Chitra Hosing, Michelle Fanale, et al.
Cytotherapy|August 26, 2010
Adoptive transfer of PR1 cytotoxic T lymphocytes associated with reduced leukemia burden in a mouse acute myeloid leukemia xenograft modelQing Ma, Changqing Wang, Dan Jones, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 7, 2022
Safety and Efficacy of Combination Maintenance Therapy with Ixazomib and Lenalidomide in Patients with Posttransplant MyelomaKrina K Patel, Jatin J Shah, Lei Feng, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 15, 2019
Comparison of Outcomes of Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma Using Three Different Conditioning RegimensHossein Maymani, Paul Lin, Rima M Saliba, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 18, 2012
Significance of persistent cytogenetic abnormalities on myeloablative allogeneic stem cell transplantation in first complete remissionBetul Oran, Uday Popat, Gabriella Rondon, et al.
American Journal of Hematology|December 11, 2022
Prognostic significance of measurable residual disease in patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation in second or later complete remissionOren Pasvolsky, Rima M Saliba, Celina Ledesma, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 15, 2009
Outcome of allogeneic hematopoietic stem cell transplantation in patients with low left ventricular ejection fractionMuzaffar H Qazilbash, Ali Imran Amjad, Suhail Qureshi, et al.
Pageof 19